Overview
- A randomized phase 2b trial published Nov. 4 found that adults with alcohol use disorder who took a standardized kudzu extract about 2.5 hours before expected heavy drinking had fewer weekly binge-drinking days than those given placebo.
- The 12-week study of 120 participants paired episodic kudzu dosing with brief weekly counseling and showed average binge days falling from 2.15 to 1.42 in the kudzu arm while remaining nearly unchanged in placebo.
- The reduction in binge days persisted at a three-month follow-up after treatment stopped and researchers reported no increase in side effects or serious adverse events linked to the study product.
- Investigators cautioned that the trial used a standardized kudzu formulation, that retail supplements vary widely in strength and purity, and that larger, more diverse trials are needed to confirm efficacy and fully assess safety and drug interactions.
- If confirmed in bigger studies, an episodic, situational pill could give people a low‑burden harm‑reduction tool to cut heavy drinking, potentially changing how clinicians and patients approach short‑term risk situations and prompting new research on dosing and long‑term effects.